Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00403-012-1304-7.

Title:
Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis | Archives of Dermatological Research
Description:
Wnt-, Hedgehog- and Notch-signaling cascades are morphogen pathways that play crucial roles in development and tissue homeostasis. While morphogen pathways are tightly regulated at multiple levels, inappropriate activation of Wnt, Hedgehog and Notch signaling has been implicated into the pathogenesis of various diseases. In particular, Wnt, Hedgehog and Notch signaling have emerged as central players in the pathogenesis of fibrotic diseases. Here, we will review the pro-fibrotic effects of Wnt, Hedgehog and Notch signaling in systemic sclerosis (SSc), prototypical systemic fibrotic disease. Wnt, Hedgehog and Notch pathways are activated in SSc. They potently stimulate fibroblasts to differentiate into myofibroblasts and to release collagen and other extracellular matrix components. Genetic or pharmacological inhibition of morphogen pathways effectively prevents experimental fibrosis in different preclinical models and induces regression of pre-established fibrosis. As several inhibitors of Wnt, Hedgehog and Notch have recently been developed with first ones being already approved for clinical trials, morphogen pathways maybe a novel approach for the treatment of fibrosis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {๐Ÿ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {๐Ÿ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {๐Ÿ“ˆ}

What is the average monthly size of link.springer.com audience?

๐ŸŒ  Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {๐Ÿ’ธ}

We can't tell how the site generates income.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {๐Ÿ”}

article, google, scholar, pubmed, cas, distler, signaling, fibrosis, systemic, sclerosis, wnt, notch, beyer, hedgehog, cell, dees, biol, rheum, schett, pathways, signalling, morphogen, activation, inhibition, akhmetshina, zerr, ann, dis, research, induces, access, canonical, dermatol, privacy, cookies, content, treatment, development, disease, experimental, palumbo, horn, zwerina, nat, dev, tomcik, arthritis, sato, arch, res,

Topics {โœ’๏ธ}

month download article/chapter tgf-beta-mediated fibrosis wnt/beta-catenin signaling functional gamma-secretase inhibitor sap18-msin3 corepressor complex canonical wnt signalling 1007/s00403-012-1292-7 yanaba pro-fibrotic wnt signaling notch-mediated transcriptional switch drugging wnt signalling related subjects reduces experimental fibrosis full article pdf wnt signaling pathways canonical wnt pathway idiopathic pulmonary fibrosis gamma-secretase inhibitors privacy choices/manage cookies human dermal fibroblasts hedgehog signalling hedgehog-gli pathway notch-signaling cascades modulating notch signaling activate notch signaling soluble inducible costimulator canonical notch ligands dermatological research aims van den born pulmonary arterial hypertension pro-fibrotic effects gastrointestinal toxicity mediated author correspondence notch ligands dll1 beta-catenin pre-established fibrosis check access instant access article beyer tsk mouse skin european economic area play crucial roles potently stimulate fibroblasts innovative antifibrotic therapies mora-blanco el goblet cells mesenchymal cells ankyrin repeat domain homeostatic stem cell arch dermatol res morphogen pathways

Questions {โ“}

  • Wei J, Melichian D, Komura K, Hinchcliff M, Lam AP, Lafyatis R, Gottardi CJ, MacDougald OA, Varga J (2011) Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?

Schema {๐Ÿ—บ๏ธ}

WebPage:
      mainEntity:
         headline:Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis
         description:Wnt-, Hedgehog- and Notch-signaling cascades are morphogen pathways that play crucial roles in development and tissue homeostasis. While morphogen pathways are tightly regulated at multiple levels, inappropriate activation of Wnt, Hedgehog and Notch signaling has been implicated into the pathogenesis of various diseases. In particular, Wnt, Hedgehog and Notch signaling have emerged as central players in the pathogenesis of fibrotic diseases. Here, we will review the pro-fibrotic effects of Wnt, Hedgehog and Notch signaling in systemic sclerosis (SSc), prototypical systemic fibrotic disease. Wnt, Hedgehog and Notch pathways are activated in SSc. They potently stimulate fibroblasts to differentiate into myofibroblasts and to release collagen and other extracellular matrix components. Genetic or pharmacological inhibition of morphogen pathways effectively prevents experimental fibrosis in different preclinical models and induces regression of pre-established fibrosis. As several inhibitors of Wnt, Hedgehog and Notch have recently been developed with first ones being already approved for clinical trials, morphogen pathways maybe a novel approach for the treatment of fibrosis.
         datePublished:2012-12-04T00:00:00Z
         dateModified:2012-12-04T00:00:00Z
         pageStart:1
         pageEnd:8
         sameAs:https://doi.org/10.1007/s00403-012-1304-7
         keywords:
            Scleroderma
            Systemic sclerosis
            Fibrosis
            Wnt
            Notch
            Hedgehog
            Dermatology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig3_HTML.gif
         isPartOf:
            name:Archives of Dermatological Research
            issn:
               1432-069X
               0340-3696
            volumeNumber:305
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christian Beyer
               affiliation:
                     name:University of Erlangen-Nuremberg
                     address:
                        name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Clara Dees
               affiliation:
                     name:University of Erlangen-Nuremberg
                     address:
                        name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jรถrg H. W. Distler
               affiliation:
                     name:University of Erlangen-Nuremberg
                     address:
                        name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Morphogen pathways as molecular targets for the treatment of fibrosis in systemic sclerosis
      description:Wnt-, Hedgehog- and Notch-signaling cascades are morphogen pathways that play crucial roles in development and tissue homeostasis. While morphogen pathways are tightly regulated at multiple levels, inappropriate activation of Wnt, Hedgehog and Notch signaling has been implicated into the pathogenesis of various diseases. In particular, Wnt, Hedgehog and Notch signaling have emerged as central players in the pathogenesis of fibrotic diseases. Here, we will review the pro-fibrotic effects of Wnt, Hedgehog and Notch signaling in systemic sclerosis (SSc), prototypical systemic fibrotic disease. Wnt, Hedgehog and Notch pathways are activated in SSc. They potently stimulate fibroblasts to differentiate into myofibroblasts and to release collagen and other extracellular matrix components. Genetic or pharmacological inhibition of morphogen pathways effectively prevents experimental fibrosis in different preclinical models and induces regression of pre-established fibrosis. As several inhibitors of Wnt, Hedgehog and Notch have recently been developed with first ones being already approved for clinical trials, morphogen pathways maybe a novel approach for the treatment of fibrosis.
      datePublished:2012-12-04T00:00:00Z
      dateModified:2012-12-04T00:00:00Z
      pageStart:1
      pageEnd:8
      sameAs:https://doi.org/10.1007/s00403-012-1304-7
      keywords:
         Scleroderma
         Systemic sclerosis
         Fibrosis
         Wnt
         Notch
         Hedgehog
         Dermatology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00403-012-1304-7/MediaObjects/403_2012_1304_Fig3_HTML.gif
      isPartOf:
         name:Archives of Dermatological Research
         issn:
            1432-069X
            0340-3696
         volumeNumber:305
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christian Beyer
            affiliation:
                  name:University of Erlangen-Nuremberg
                  address:
                     name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Clara Dees
            affiliation:
                  name:University of Erlangen-Nuremberg
                  address:
                     name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jรถrg H. W. Distler
            affiliation:
                  name:University of Erlangen-Nuremberg
                  address:
                     name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Archives of Dermatological Research
      issn:
         1432-069X
         0340-3696
      volumeNumber:305
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Erlangen-Nuremberg
      address:
         name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nuremberg
      address:
         name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nuremberg
      address:
         name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christian Beyer
      affiliation:
            name:University of Erlangen-Nuremberg
            address:
               name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Clara Dees
      affiliation:
            name:University of Erlangen-Nuremberg
            address:
               name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Jรถrg H. W. Distler
      affiliation:
            name:University of Erlangen-Nuremberg
            address:
               name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
      name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
      name:Department of Internal Medicine 3, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {๐Ÿ”—}(166)

Analytics and Tracking {๐Ÿ“Š}

  • Google Tag Manager

Libraries {๐Ÿ“š}

  • Clipboard.js
  • Prism.js

CDN Services {๐Ÿ“ฆ}

  • Crossref

4.15s.